vs

Side-by-side financial comparison of ACNB CORP (ACNB) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

ACNB CORP is the larger business by last-quarter revenue ($47.2M vs $38.9M, roughly 1.2× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 22.9%, a 1.8% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 42.2%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 22.1%).

ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

ACNB vs CDXS — Head-to-Head

Bigger by revenue
ACNB
ACNB
1.2× larger
ACNB
$47.2M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+39.1% gap
CDXS
81.3%
42.2%
ACNB
Higher net margin
CDXS
CDXS
1.8% more per $
CDXS
24.7%
22.9%
ACNB
More free cash flow
ACNB
ACNB
$33.0M more FCF
ACNB
$52.6M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
22.1%
ACNB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNB
ACNB
CDXS
CDXS
Revenue
$47.2M
$38.9M
Net Profit
$10.8M
$9.6M
Gross Margin
94.8%
Operating Margin
27.9%
27.1%
Net Margin
22.9%
24.7%
Revenue YoY
42.2%
81.3%
Net Profit YoY
63.8%
192.5%
EPS (diluted)
$1.10
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNB
ACNB
CDXS
CDXS
Q4 25
$47.2M
$38.9M
Q3 25
$50.9M
$8.6M
Q2 25
$50.3M
$15.3M
Q1 25
$43.5M
$7.5M
Q4 24
$33.2M
$21.5M
Q3 24
$34.1M
$12.8M
Q2 24
$33.3M
$8.0M
Q1 24
$31.6M
$17.1M
Net Profit
ACNB
ACNB
CDXS
CDXS
Q4 25
$10.8M
$9.6M
Q3 25
$14.9M
$-19.6M
Q2 25
$11.6M
$-13.3M
Q1 25
$-272.0K
$-20.7M
Q4 24
$6.6M
$-10.4M
Q3 24
$7.2M
$-20.6M
Q2 24
$11.3M
$-22.8M
Q1 24
$6.8M
$-11.5M
Gross Margin
ACNB
ACNB
CDXS
CDXS
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
ACNB
ACNB
CDXS
CDXS
Q4 25
27.9%
27.1%
Q3 25
37.2%
-220.3%
Q2 25
29.7%
-83.9%
Q1 25
-1.3%
-271.6%
Q4 24
24.8%
-34.2%
Q3 24
27.6%
-129.0%
Q2 24
42.8%
-284.9%
Q1 24
26.9%
-69.6%
Net Margin
ACNB
ACNB
CDXS
CDXS
Q4 25
22.9%
24.7%
Q3 25
29.2%
-228.1%
Q2 25
23.2%
-86.6%
Q1 25
-0.6%
-274.3%
Q4 24
19.9%
-48.4%
Q3 24
21.1%
-160.8%
Q2 24
33.9%
-285.2%
Q1 24
21.4%
-67.4%
EPS (diluted)
ACNB
ACNB
CDXS
CDXS
Q4 25
$1.10
$0.13
Q3 25
$1.42
$-0.22
Q2 25
$1.11
$-0.16
Q1 25
$-0.03
$-0.25
Q4 24
$0.77
$-0.12
Q3 24
$0.84
$-0.29
Q2 24
$1.32
$-0.32
Q1 24
$0.80
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNB
ACNB
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$65.6M
$78.2M
Total DebtLower is stronger
$255.4M
$40.1M
Stockholders' EquityBook value
$420.0M
$50.5M
Total Assets
$3.2B
$147.8M
Debt / EquityLower = less leverage
0.61×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNB
ACNB
CDXS
CDXS
Q4 25
$65.6M
$78.2M
Q3 25
$102.1M
$58.7M
Q2 25
$103.1M
$66.3M
Q1 25
$123.6M
$59.8M
Q4 24
$47.3M
$73.5M
Q3 24
$58.1M
$90.3M
Q2 24
$86.3M
$73.2M
Q1 24
$53.1M
$85.5M
Total Debt
ACNB
ACNB
CDXS
CDXS
Q4 25
$255.4M
$40.1M
Q3 25
$255.4M
$39.7M
Q2 25
$255.4M
$39.4M
Q1 25
$255.3M
$29.2M
Q4 24
$255.3M
$28.9M
Q3 24
$255.3M
$28.6M
Q2 24
$255.3M
$28.4M
Q1 24
$255.3M
$28.1M
Stockholders' Equity
ACNB
ACNB
CDXS
CDXS
Q4 25
$420.0M
$50.5M
Q3 25
$408.6M
$38.5M
Q2 25
$395.2M
$55.6M
Q1 25
$386.9M
$49.6M
Q4 24
$303.3M
$66.9M
Q3 24
$306.8M
$73.4M
Q2 24
$289.3M
$61.4M
Q1 24
$279.9M
$79.3M
Total Assets
ACNB
ACNB
CDXS
CDXS
Q4 25
$3.2B
$147.8M
Q3 25
$3.3B
$124.0M
Q2 25
$3.3B
$138.2M
Q1 25
$3.3B
$128.9M
Q4 24
$2.4B
$149.0M
Q3 24
$2.4B
$148.2M
Q2 24
$2.5B
$132.0M
Q1 24
$2.4B
$149.6M
Debt / Equity
ACNB
ACNB
CDXS
CDXS
Q4 25
0.61×
0.79×
Q3 25
0.62×
1.03×
Q2 25
0.65×
0.71×
Q1 25
0.66×
0.59×
Q4 24
0.84×
0.43×
Q3 24
0.83×
0.39×
Q2 24
0.88×
0.46×
Q1 24
0.91×
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNB
ACNB
CDXS
CDXS
Operating Cash FlowLast quarter
$53.6M
$20.1M
Free Cash FlowOCF − Capex
$52.6M
$19.6M
FCF MarginFCF / Revenue
111.4%
50.3%
Capex IntensityCapex / Revenue
2.3%
1.3%
Cash ConversionOCF / Net Profit
4.96×
2.09×
TTM Free Cash FlowTrailing 4 quarters
$92.2M
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNB
ACNB
CDXS
CDXS
Q4 25
$53.6M
$20.1M
Q3 25
$23.2M
$-7.7M
Q2 25
$17.8M
$-18.0M
Q1 25
$-71.0K
$-13.8M
Q4 24
$39.8M
$-16.5M
Q3 24
$13.6M
$-13.0M
Q2 24
$9.7M
$-12.2M
Q1 24
$10.8M
$-7.8M
Free Cash Flow
ACNB
ACNB
CDXS
CDXS
Q4 25
$52.6M
$19.6M
Q3 25
$22.8M
$-7.9M
Q2 25
$17.6M
$-20.5M
Q1 25
$-730.0K
$-15.1M
Q4 24
$38.8M
$-18.2M
Q3 24
$13.3M
$-14.0M
Q2 24
$9.4M
$-12.6M
Q1 24
$10.7M
$-8.9M
FCF Margin
ACNB
ACNB
CDXS
CDXS
Q4 25
111.4%
50.3%
Q3 25
44.7%
-91.7%
Q2 25
35.0%
-133.6%
Q1 25
-1.7%
-199.6%
Q4 24
117.0%
-85.0%
Q3 24
39.1%
-109.0%
Q2 24
28.3%
-157.5%
Q1 24
33.9%
-52.2%
Capex Intensity
ACNB
ACNB
CDXS
CDXS
Q4 25
2.3%
1.3%
Q3 25
0.8%
2.1%
Q2 25
0.4%
16.4%
Q1 25
1.5%
16.7%
Q4 24
2.9%
8.3%
Q3 24
0.7%
7.8%
Q2 24
0.9%
5.0%
Q1 24
0.2%
6.6%
Cash Conversion
ACNB
ACNB
CDXS
CDXS
Q4 25
4.96×
2.09×
Q3 25
1.56×
Q2 25
1.52×
Q1 25
Q4 24
6.03×
Q3 24
1.88×
Q2 24
0.86×
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons